The identification of key players in HNSCC such as FAT1 and PI3K as regulators of the Hippo-YAP pathway, as well as the activation of YAP as a relevant oncogenic mechanism in head and neck cancer opens the way for the use of different therapeutic strategies targeting this pathway in this tumor type. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.